How New Lung Cancer Data And Updated COVID Shot At BioNTech (BNTX) Has Changed Its Investment Story

In mid-September 2026, Pfizer Canada and BioNTech announced Health Canada’s approval of the Omicron XFG‑adapted COMIRNATY vaccine for individuals aged 6 months and older, aligning with 2026–2027 public health recommendations. A few days earlier, BioNTech and OncoC4 reported that investigational CTLA‑4 antibody gotistobart nearly doubled median overall survival versus chemotherapy in a Phase 3 lung cancer trial stage, underscoring BioNTech’s expanding presence in late‑stage oncology. We’ll...